Clopidogrel Articles
Sanofi buys Colombian drugmaker; Presents encouraging eliglustat and Lyxumia data; Revizes deal with B-MS
3 October 2012
US genericization of clopidogrel will initially contract ACS market, before uptake of novel oral agents lifts sector to $2.7 billion
27 August 2012
Sanofi fourth-quarter in line with forecasts; collects damages
8 February 2012
Clopidogrel with aspirin does not prevent more small strokes
5 February 2012
China’s acute coronary syndrome drug market forecast to grow to nearly $450 million in 2015
22 November 2011
US FDA grants pediatric exclusivity for Sanofi/B-MS Plavix; rejects Gilead’s filing for combination AIDS pill
26 January 2011
Sanofi-Aventis CEO reasonably confident of doing deal for Genzyme, but in no hurry
16 September 2010
UK’s NICE issues guidance on blood clotting drugs Plavix and Persantin/Asasantin; PMCPA consults on ABPI Code of Practice
6 August 2010
EMEA recalls batches of generic Plavix; Sun Pharma withdraws EU marketing application for Repaglinide SUN
26 March 2010
UK’s NICE sets national standard for neuropathic pain drug treatments in non-specialist NHS settings; guidance on angina
25 March 2010
Allergan sells Bristol-Myers Squibb rights to early-stage pain drug for up to $413 million
4 March 2010
Big pharma struggles to benefit from increased CVD drug usage in market set to grow to $107 billion in 2018
3 March 2010
US generics group GPhA “deeply disappointed" with Obama Administration's health care proposal
23 February 2010
Sanofi-Aventis 2009 EPS leaps 18% but slows in 4th quarter; in line with expectations
10 February 2010
Poland’s pharma distribution seeing many changes, with significant consolidation among wholesalers
9 February 2010
Bristol-Myers Squibb forecasts large jump in 2010 profit to range of $1.94 to $2.04 per share
29 January 2010
Generic erosion will bite into the acute coronary syndrome market, cutting sales nearly 10% from 2008 to 2018
8 December 2009
AstraZeneca presents strong Ph II results for Brilinta at AHA, beating Plavix; files drug with FDA
19 November 2009
US FDA warns against use of PPI Prilosec with Plavix
18 November 2009
Bristol-Myers Squibb decides to split off Mead Johnson nutritional unit to concentrate on biopharma
17 November 2009
Sanofi-Aventis says strong swine flu vaccine sales in 4th quarter will drive higher earnings
30 October 2009
Bristol-Myers sees 64% leap in 3rd quarter 2009 ongoing earnings
23 October 2009
Bristol-Myers Squibb says USPTO to review Plavix patent
20 August 2009
Stock Commentary - Europe - week to June 1, 2009
4 June 2009
EMEA's CHMP gives nod to six Plavix generics
2 June 2009
Retail drug sales in year to March 2009
22 May 2009
Stock Commentary - Europe - week to may 11, 2009
14 May 2009
B-MS' 1st qtr hit by tax and legal costs
29 April 2009
CHMP meeting sees good news for AZ, but not for Teva
24 April 2009
Retail drug sales in year to February 2009
24 April 2009
Sanofi relocates plant to Binjiang
22 April 2009
Bristol-Myers Squibb an attractive value
14 April 2009
Record sales for Sanofi Japan, says president
14 April 2009
Daiichi/Lilly's Efient gets first world launch in UK - first new antiplatelet drug in a decade
9 April 2009
B-MS exec pleads guilty to anti-trust dealings
7 April 2009
Retail drug sales in year to January 2009
3 April 2009
B-MS to pay $2.1M settlement to FTC
1 April 2009
Aspirin more effective with Plavix in AF
1 April 2009
US drug sales growth slows to 1.3%
30 March 2009
Retail drug sales in year to December 2008
30 March 2009
Thailand "threat" to USA over CL policy
16 March 2009
Prasugrel lowers HF risk in high-risk patients
9 March 2009
Japan stock market week to March 2, 2009
9 March 2009
Lilly/Daiichi's Efient cleared in Europe
2 March 2009
Thailand group fights EU-ASEAN FTA
2 March 2009
"30,000" fake drug packs given to NHS patients
9 February 2009
Sanofi has $5.1B and is looking for M&A deals
9 February 2009
Retail drug sales in year to November 2008
26 January 2009
Gene variant reduces Plavix effectiveness
12 January 2009
US Court rules Plavix patent valid to 2011
22 December 2008
Retail drug sales in year to October 2008
22 December 2008
S-P claims superior pipeline to competitors; new drugs could make $7B in next 4 years
8 December 2008
AstraZeneca axes jobs, closes plants
1 December 2008
Sale of Ratiopharm being considered?
24 November 2008
Sanofi successfully defends Plavix patent in Canada
17 November 2008
Retail drug sales in year to September 2008
17 November 2008
Medco study suggests PPIs inhibit B-MS' Plavix
17 November 2008
deCODE presents AF test data at AHA
17 November 2008
Sanofi/B-MS publish Plavix trial design
10 November 2008
Bristol-Myers Squibb's 3rd-qtr 2008 profit triples due to big gain from $4.1B sales of ConvaTec
3 November 2008
Stock Commentary - Europe - week to Oct 20, 2008
27 October 2008
Retail drug sales in year to August 2008
20 October 2008
Retail drug sales in year to July 2008
22 September 2008
Japan stock market week to Sept 1, 2008
8 September 2008
UPDATE: Prasugrel better than Plavix in preventing ACS in diabetics
8 September 2008
Recurrent events 35% less likely with prasugrel than Plavix
1 September 2008
Retail drug sales in year to June 2008
18 August 2008
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
